Impact of Preanalytical Procedures on Complement Biomarkers in Cerebrospinal Fluid and Plasma from Controls and Alzheimer’s Disease Patients
Our findings provide recommendations for CSF/plasma sample handling to ensure robust and reproducible complement biomarker analyses in AD.
Authors
- Robert Perneczky (ORCID: https://orcid.org/0000-0003-1981-7435)
- Rose Edmonds (ORCID: https://orcid.org/0000-0001-8544-6439)
- Anne Biever (ORCID: https://orcid.org/0000-0002-0941-4301)
- Carolin Kurz (ORCID: https://orcid.org/0000-0003-4299-6240)
- Cosme Sandoval
- Tobias Bittner (ORCID: https://orcid.org/0000-0001-9256-0360)
- Johnny Gutierrez
Institutions
- German Center for Neurodegenerative Diseases (DE)
- LMU Klinikum (DE)
- Munich Cluster for Systems Neurology (DE)
- Imperial College London (GB)
- Ludwig-Maximilians-Universität München (DE)
- University of Sheffield (GB)
Publication Details
- Journal
- Journal of Alzheimer s Disease
- Published
- 2024-08-30
- DOI
- https://doi.org/10.3233/jad-240287
- Citations
- 2
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.49
Funders
- Genentech